Introduction
Clopivas 75 Tablet is a prescription medicine produced by Cipla Ltd. It contains the active ingredient Clopidogrel (75mg). This medication falls under the therapeutic class of BLOOD RELATED drugs and belongs to the chemical class of Alpha amino acid esters. Clopivas 75 Tablet is classified as a P2Y12 inhibitor, specifically targeting the ADP receptor. It is mainly used for the prevention of heart attacks and strokes.
Uses
Clopivas 75 Tablet is primarily used to prevent heart attacks and strokes. It is prescribed by healthcare providers to individuals at high risk of these cardiovascular events. This medication works by inhibiting platelet aggregation, thereby reducing the risk of blood clots forming in the arteries that can lead to heart attacks or strokes.
Price
The Maximum Retail Price (MRP) of Clopivas 75 Tablet is ₹84.6 for a pack containing 15 tablets in 1 strip.
Dosage
Patients are advised to take Clopivas 75 Tablet in the dose and duration prescribed by their healthcare provider. It is essential to swallow the tablet whole and not crush, chew, or break it. The medication can be taken with or without food, but it is recommended to take it at a fixed time each day for optimal effectiveness.
Benefits
The primary benefit of Clopivas 75 Tablet is its ability to prevent heart attacks and strokes by reducing the formation of blood clots in the arteries. By inhibiting platelet aggregation, this medication helps maintain healthy blood flow and reduces the risk of serious cardiovascular events.
Side Effects
While Clopivas 75 Tablet is generally well-tolerated, some individuals may experience side effects, with the most common being bleeding. Patients should seek medical attention if they encounter any severe or persistent side effects while taking this medication.
Active Ingredients
Clopivas 75 Tablet contains the active ingredient Clopidogrel at a dosage of 75mg per tablet. Clopidogrel is a widely used antiplatelet medication that helps prevent blood clot formation.
Pharmacological Properties
Clopidogrel, the active ingredient in Clopivas 75 Tablet, works by irreversibly binding to the P2Y12 ADP receptor on platelets. This binding inhibits platelet activation and aggregation, reducing the risk of thrombus formation and subsequent cardiovascular events.
Indications
Clopidogrel, present in Clopivas 75 Tablet, is indicated for the prevention of atherothrombotic events in patients with a history of cardiovascular diseases or at risk of such events. It is commonly prescribed following procedures like angioplasty or stent placement to prevent blood clots.
Contraindications
This medicine is contraindicated in individuals with a known hypersensitivity to Clopidogrel or any of the tablet’s components. Patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage should also avoid taking Clopivas 75 Tablet.
Drug Interactions
Patients should be cautious while taking Clopivas 75 Tablet along with other medications that affect blood clotting, such as anticoagulants or nonsteroidal anti-inflammatory drugs (NSAIDs). It is essential to inform the healthcare provider about all the medications being taken to avoid potential drug interactions.
Patient Counseling
Patients should follow the prescribed dosage and schedule for taking Clopivas 75 Tablet. They should not alter the dose or discontinue the medication without consulting their healthcare provider. It is advisable to report any unusual or persistent side effects to the doctor promptly.
Clinical Evidence
Several clinical studies have demonstrated the efficacy of Clopidogrel, the active ingredient in Clopivas 75 Tablet, in preventing cardiovascular events. Data from large-scale trials have shown a significant reduction in heart attacks, strokes, and other cardiovascular complications in patients treated with Clopidogrel compared to a placebo or other antiplatelet medications.
Frequently Asked Questions (FAQs)
Q: How should I take Clopivas 75 Tablet?
A: Clopivas 75 Tablet should be taken as prescribed by your healthcare provider. Swallow the tablet whole with water, and do not crush, chew, or break it. Follow a consistent schedule for taking the medication to maximize its benefits.
Q: What are the common side effects of Clopivas 75 Tablet?
A: The most common side effect of Clopivas 75 Tablet is bleeding. Other side effects may include gastrointestinal disturbances or allergic reactions. Consult your doctor if you experience any severe or persistent side effects while taking this medication.
Q: Can I take Clopivas 75 Tablet with other medications?
A: It is essential to inform your healthcare provider about all the medications, supplements, or herbal products you are taking before starting Clopivas 75 Tablet to avoid potential drug interactions. Some medications may affect the action of Clopidogrel, so it is crucial to seek medical advice.
Q: Is Clopivas 75 Tablet habit-forming?
A: No, Clopivas 75 Tablet is not habit-forming. It is a prescribed medication that should be used according to the doctor’s instructions for the indicated duration.
Q: What should I do if I miss a dose of Clopivas 75 Tablet?
A: If you forget to take a dose of Clopivas 75 Tablet, take it as soon as you remember. However, if it is almost time for the next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to compensate for the missed one.
MRP:
₹84.6
Manufacturer:
Cipla Ltd
Salt:
Clopidogrel (75mg),
How to UseClopivas 75 Tablet:
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Clopivas 75 Tablet may be taken with or without food, but it is better to take it at a fixed time.
Side Effects of Clopivas 75 Tablet:
Bleeding,
Alternate Medicines for Clopivas 75 Tablet:
Clopikind Tablet,Clopiheart 75mg Tablet,Deplatt Tablet,Plagril 75 Tablet,Clopitab Tablet,
Prescription Required Status:
Prescription Required
Type of Selection:
15 tablets in 1 strip
Chemical Class:
Alpha amino acid esters
Habit Forming:
No
Therapeutic Class:
BLOOD RELATED
Action Class:
P2Y12 inhibitors (ADP receptor)
. Please note, this information is for educational purposes only and not intended as medical advice.
